bioAffinity Technologies plans to use management presentation materials during the H.C. Wainwright Global Investment Conference from September 14 through September 16, 2026. The materials are intended for presentations covering the company’s operations and performance, giving investors a scheduled setting for management’s communication about those areas.
Key Highlights
- Management intends to use the presentation materials on multiple occasions.
- Maria Zannes signed the disclosure on September 11, 2026, as president and chief executive officer.
- The materials address bioAffinity Technologies’ operations and performance.
BioAffinity Technologies, Inc. (NASDAQ: BIAF) plans to use management presentation materials during the H.C. Wainwright Global Investment Conference from September 14 through September 16, 2026. The company is incorporated in Delaware. Maria Zannes signed the disclosure on September 11, 2026, in her capacity as president and chief executive officer.
Management Materials Set for H.C. Wainwright Conference
BioAffinity Technologies’ management plans to use the prepared materials during presentations connected with the event. Maria Zannes signed on behalf of bioAffinity Technologies as president and chief executive officer.
FAQs
Q: What did bioAffinity Technologies disclose in the filing?
A: BioAffinity Technologies disclosed that management presentation materials. The materials are intended for use during the H.C. Wainwright Global Investment Conference.
Q: When does the filing identify the H.C. Wainwright conference?
A: The filing identifies the H.C. Wainwright 28th Annual Global Investment Conference as being held from September 14, 2026, through September 16, 2026. The company says management intends to use its materials at the conference.
Q: What materials does BioAffinity Technologies plan to use at the H.C. Wainwright Global Investment Conference?
A: BioAffinity Technologies plans to use management presentation materials during the H.C. Wainwright Global Investment Conference. The materials are prepared for presentations connected with the event.
Q: Where is BioAffinity Technologies incorporated, and what is its stock ticker?
A: BioAffinity Technologies is incorporated in Delaware. The disclosure identifies the company as BioAffinity Technologies, Inc. and lists its NASDAQ ticker as BIAF.
Download Free Report – Explore 3 Stock Ideas & Industry Insights
Unlock 3 stock ideas and key industry insights in our free report. This information is general in nature and does not consider your personal objectives, financial situation, or needs. It is not financial advice.
All investments involve risk—consider independent advice before making any investment decisions.
View 3 Research Reports
Disclaimer:
Kalkine Equities LLC, with Delaware File Number 4697384, Foreign Qualification Registration in California File Number 202109211078, and Texas File Number 805521396, is authorized to provide general advice only. The information on https://kalkine.com/ does not take into account any of your investment objectives, financial situation or needs. You should consider the appropriateness of advice taking into account your own objectives, financial situation and needs and seek independent financial advice before making any financial decisions. The link to our Terms and Conditions and Privacy Policy has been provided for your reference. On the date of publishing the reports (mentioned on the website), employees and/or associates of Kalkine do not hold positions in any of the stocks covered on the website. These stocks can change any time and readers of the reports should not consider these stocks as advice or recommendations later.